Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK1A1 | P48729 | 1/20 | 1.00 |
| ▸ | TYRO3 | Q06418 | 1/20 | 1.00 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 1.00 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.55 |
| ▸ | PARP1 | P09874 | 3/20 | 0.52 |
| ▸ | BCAT2 | O15382 | 1/20 | 0.49 |
| ▸ | MTOR | P42345 | 1/20 | 0.46 |
| ▸ | ADK | P55263 | 1/20 | 0.46 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.46 |
| ▸ | HCRTR1 | O43613 | 2/20 | 0.46 |
| ▸ | HCRTR2 | O43614 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | GRM5 | P41594 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | BTK | Q06187 | 1/20 | 0.42 |
| ▸ | IDO1 | P14902 | 1/20 | 0.42 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.40 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.40 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL30473073 | 0.98 | CSNK1A1 (0.97) | CSNK1A1TYRO3DYRK1BNUDT1PARP1 | |
| SCHEMBL10714674 | 0.86 | CSNK1A1 (0.76) | CSNK1A1TYRO3DYRK1BNUDT1PARP1 | |
| SCHEMBL297622 | 0.85 | CSNK1A1 (0.73) | CSNK1A1TYRO3DYRK1BMTORADK | |
| SCHEMBL30965100 | 0.85 | CSNK1A1 (0.73) | CSNK1A1TYRO3DYRK1BMTORADK | |
| SCHEMBL4564865 | 0.84 | CSNK1A1 (0.73) | CSNK1A1TYRO3DYRK1BNUDT1PARP1 | |
| SCHEMBL15478263 | 0.83 | CSNK1A1 (0.71) | CSNK1A1TYRO3DYRK1BPARP1MTOR | |
| SCHEMBL31661863 | 0.83 | CSNK1A1 (0.71) | CSNK1A1TYRO3DYRK1BNUDT1PARP1 | |
| SCHEMBL11566235 | 0.83 | CSNK1A1 (0.71) | CSNK1A1TYRO3DYRK1BNUDT1PARP1 | |
| SCHEMBL9234252 | 0.83 | CSNK1A1 (0.71) | CSNK1A1TYRO3DYRK1BNUDT1PARP1 | |
| Hydrochloric Acid SCHEMBL5854599 | 0.83 | CSNK1A1 (0.71) | CSNK1A1TYRO3DYRK1BMTORADK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025106897-A1 | METHODS AND COMPOSITIONS FOR CREATING INDUCED PLURIPOTENT STEM CELLS | COLOSSAL BIOSCIENCES INC. (US) | 2025-05-22 | — | — | WO | disclosed |
| WO-2023240157-A2 | COMPOSITIONS AND METHODS FOR THE TARGETING OF DMD | SCRIBE THERAPEUTICS INC. (US) | 2023-12-14 | — | — | WO | disclosed |
| CN-107428740-A | Indazolyl-and indolyl-benzamide derivatives | 埃萨内克斯股份有限公司 | 2017-12-01 | — | — | CN | disclosed |
| CN-104105545-B | preparation of olefin oligomerization catalyst | 切弗朗菲利浦化学公司 | 2017-07-04 | — | — | CN | disclosed |
| CN-104105545-A | Preparation of olefin oligomerization catalyst | CHEVRON PHILLIPS CHEMICAL COMOANY LP | 2014-10-15 | — | — | CN | disclosed |
| US-8772507-B2 | Imidazole-benzamide anti-cancer agents | CYTOKINETICS, INC. (US) | 2014-07-08 | — | — | US | disclosed |
| US-8252831-B2 | Imidazole-2-benzamide compounds useful for the treatment of osteoarthritis | ELI LILLY AND COMPANY (US) | 2012-08-28 | — | — | US | disclosed |
| US-20120157506-A1 | Novel Imidazole-2-Benzamide Compounds Useful for the Treatment of Osteoarthritis | ELI LILLY AND COMPANY (US) | 2012-06-21 | — | — | US | disclosed |
| CN-101218234-B | Phenyl-3-{(3-(1H-pyrrol-2-yl)-[1,2,4]oxadiazol-5-yl]piperidin-1-yl}-methanone derivatives and related compounds as positive allosteric modulators of metabotropic glutamate receptors | ADDEX PHARMA S.A. (CH) | 2011-12-14 | — | — | CN | disclosed |
| CN-100484935-C | benzimidazole derivatives as factor Xa inhibitors | SANOFI AVENTIS DEUTSCHLAND (DE) | 2009-05-06 | — | — | CN | disclosed |
| CN-101218234-A | Phenyl-3-{(3-(1H-pyrrol-2-yl)-[1,2,4]oxadiazol-5-yl]piperidin-1-yl}-methanone derivatives and related compounds as positive allosteric modulators of metabotropic glutamate receptors | ADDEX PHARMACEUTICALS SA (CH) | 2008-07-09 | — | — | CN | disclosed |
| CN-101139346-A | Benzimidazole-derivatives as factor Xa inhibitors | SANOFI AVENTIS DEUTSCHLAND (DE) | 2008-03-12 | — | — | CN | disclosed |
| CN-1791598-A | benzimidazole derivatives as factor Xa inhibitors | SANOFI AVENTIS DEUTSCHLAND (DE) | 2006-06-21 | — | — | CN | disclosed |
| WO-2004089877-A1 | NEW HYDROXYNAPHTHYL AMIDES | ASTRAZENECA AB (SE) | 2004-10-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120157506-A1 | Novel Imidazole-2-Benzamide Compounds Useful for the Treatment of Osteoarthritis | ARG2, HDAC6, COL2A1 | CSNK1A1 2093/4885TYRO3 774/4885DYRK1B 2952/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.